First UK patient treated with CSL Behring’s gene therapy for Haemophilia B
June 20, 2025Research and Development CSL Behring, Haematology, NHS England, cell therapy, gene therapy, haemophilia B, prophylactic infusions
CSL Behring has announced that the first patient in the UK has received HEMGENIX (etranacogene dezaparvovec) through the NHS, marking …
Eyestem completes phase 1 trial of retinal cell therapy with promising vision gains
June 20, 2025Research and Development Eyestem Research, Opthalmology, cell therapy, clinical trial, dry age-related macular degeneration, geographic atrophy
Eyestem Research has announced the successful completion of its phase 1 trial evaluating Eyecyte-RPE, an investigational cell therapy for geographic …
Nanoform receives €5m loan from Finnish government to accelerate its nanotechnology
June 20, 2025Freelancers, Licensing & business development, Research and Development Devices, Johnson & Johnson, Nanoform Finland, Oncology, amorphous solid dispersion technology, government loan, nanoparticle medicine, nanotechnology, prostate cancer
Nanoform Finland [Nanoform], a leading nanoparticle medicine company, is pleased to announce that Business Finland has approved a €5m research …
Celltrion opens new UK headquarters in Uxbridge to drive long-term growth
June 19, 2025Research and Development Corporate, Pharmacy, biosimilar medicines, celltrion
Celltrion, focused on the development of biosimilar medicines, has officially opened its new UK headquarters in the Charter Building, Uxbridge, …
KFSHRC and Germfree to launch first modular ATMP manufacturing campus in Saudi Arabia
June 19, 2025Medical Communications, Research and Development Advanced Therapy Medicinal Product manufacturing, BIO 2025, Corporate, King Faisal Specialist Hospital & Research Centre, Saudi Arabia, biotechnology development, cell therapies, gene therapies
King Faisal Specialist Hospital & Research Centre (KFSHRC) has announced a landmark partnership with Germfree Laboratories to develop Saudi Arabia’s …
Alan Perkins awarded MBE for services to patient care and clinical science
June 19, 2025Medical Communications Devices, MBE, Serac Life Sciences, medical imaging technology, molecular imaging, nuclear medicine, scientific advisor
Serac Life Sciences has announced that Alan Perkins, scientific advisor to its subsidiaries Serac Healthcare and Serac Imaging Systems, has …
Bristol Myers Squibb to present positive new data on lymphoma treatment
June 18, 2025Medical Communications, Research and Development Bristol Myers Squibbs, CAR T-cell therapy, International Conference on Malignant Lymphoma, Oncology, relapsed or refractory marginal zone lymphoma
Bristol Myers Squibb (BMS) has announced positive results from the TRANSCEND FL phase 2 study evaluating Breyanzi (lisocabtagene maraleucel; liso-cel) …
Captain T Cell joins Bayer Co.Lab Berlin to accelerate TCR therapies
June 18, 2025Analytical & Laboratory Services, Business Services, Research and Development Bayer Co.Lab, Bayer Co.Lab Berlin, Captain T Cell, Corporate, T-cell receptor therapy, laboratory services
Captain T Cell, a biotech company developing next-generation T-cell receptor (TCR)-based therapies for solid tumours, has announced its selection for …
EVerZom receives €3m funding from French government to industrialise exosome technology
June 18, 2025Research and Development BpiFfrance, Corporate, Crohn’s disease, EVerZom, France 2030, French government, age-related disorders, exosome therapy, neurodegenerative disease
EVerZom, a French biopharma company focused on exosome-based therapies, has announced it has received €3m in funding as part of …
Samra Turajlić appointed director of Cancer Research UK Manchester Institute
June 18, 2025Medical Communications, Research and Development Cancer Research UK, Cancer Research UK Manchester Institute, Oncology, The Royal Marsden NHS Foundation Trust, University of Manchester, cancer research
Cancer Research UK has announced the appointment of Samra Turajlić as the new director of the Cancer Research UK Manchester …
Smartphone app for treating depression launches in UK
June 17, 2025Clinical & Scientific, Freelancers NHS trusts, Psychiatry, Rejoyn, digital therapeutics, major depressive disorder, mental health
Otsuka and Click Therapeutics have launched Rejoyn, a prescription digital therapeutic for major depressive disorder (MDD), in the UK. The …
Astoriom appoints Brittany Jackson as CFO
June 17, 2025Business Services Astoriom, Corporate, R&D sample stability and biorepository storage, cfo
Astoriom, a R&D sample stability and biorepository storage company, has appointed Brittany Jackson as chief financial officer (CFO). Jackson will …
Biotium launches new DNA gel analysis technology
June 17, 2025Business Services, Research and Development Biotium, Corporate, DNA gel analysis, DNAzure blue nucleic acid gel stain, glo-plate white photoactivation device, life sciences reagents
Biotium has announced the launch of its new glo-plate white photoactivation device, a compact LED-powered light box designed to support …
Scientists discover reason for resistance to bowel cancer treatment
June 17, 2025Research and Development Cancer Research UK, Oncology, The Institute of Cancer Research, bowel cancer, drug resistance
Scientists funded by Cancer Research UK have demonstrated what may cause some treatments to stop working in people living with …
Johnson & Johnson presents promising data on leukaemia treatment
June 16, 2025Medical Communications, Research and Development European Hematology Association, Janssen-Cilag, Johnson & Johnson, Oncology, chronic lymphocytic leukaemia, clinical trial
Janssen-Cilag, a Johnson & Johnson company, has announced results from a matching-adjusted indirect comparison presented at this year’s European Hematology …
GCI Health appoints Aneeb Sharif as EMEA head of policy
June 16, 2025Business Services, Medical Communications, Public Relations Corporate, EMEA Head of Policy, GCI Health, healthcare communications agency, healthcare policy analysis, patient advocacy, public affairs
Healthcare communications agency, GCI Health, has announced the appointment of Aneeb Sharif as Europe, Middle East and Africa (EMEA) head …
Roche advances treatment for Parkinson’s disease
June 16, 2025Research and Development Neurology, Parkinson's disease, Roche, clinical trials, neurodegenerative disease
Swiss biopharma, Roche, has announced its decision to proceed with phase 3 trials of prasinezumab, an investigational therapy for Parkinson’s …
Shilpa Medicare and Orion partner, expanding into European market
June 16, 2025Manufacturing and Production Corporate, Orion Corporation, Shilpa Biocare, Shilpa Medicare, commercial supply agreement, plasma protein, recombinant human albumin
Shilpa Biocare, a wholly owned subsidiary of Shilpa Medicare, has signed a commercial supply agreement with Finland-based Orion Corporation for …
Bristol Myers Squibb reports positive results for psoriatic arthritis treatment
June 13, 2025Medical Communications, Research and Development European Alliance of Associations for Rheumatology, Rheumatology, bristol myers squibb, clinical trial, psoriatic arthritis
Bristol Myers Squibb (BMS) has presented new data from its phase 3 POETYK PsA-1 trial, showing that Sotyktu (deucravacitinib) significantly …
EpiEndo publishes new data supporting glasmacinal’s potential in COPD
June 13, 2025Medical Communications, Research and Development Chronic Diseases, EpiEndo Pharmaceuticals, Fraunhofer Institute for Toxicology and Experimental Medicine, antimicrobial resistance, chronic obstructive pulmonary disease (COPD), lung disease
EpiEndo Pharmaceuticals has announced the publication of three peer-reviewed articles in Pulmonary Pharmacology and Therapeutics, highlighting the therapeutic potential of …
Latest content
FibroFind appoints Lee Borthwick as CEO
